Park Avenue Securities’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
SIMG
BTCPP
FWIA
RP
CCA
BCM
AA
Park Avenue Securities's TECH Position: Q2 2026 in Review
Park Avenue Securities sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 5,283 shares — an estimated $276K sold.
Park Avenue Securities first reported a position in TECH in Q4 2019 and held it in 25 quarters. The position peaked at $1.7M in Q4 2021. 174 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Park Avenue Securities reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
- Park Avenue Securities sold 5,283 Bio-Techne shares in Q2 2026, an estimated $276K.
- Park Avenue Securities first reported a position in Bio-Techne in Q4 2019 and held it in 25 quarters.
- Park Avenue Securities's Bio-Techne position peaked at $1.7M in Q4 2021.
- 174 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.